Substrate receptors of proteasomes

© 2018 Cambridge Philosophical Society..

Proteasomes are responsible for the turnover of most cellular proteins, and thus are critical to almost all cellular activities. A substrate entering the proteasome must first bind to a substrate receptor. Substrate receptors can be classified as ubiquitin receptors and non-ubiquitin receptors. The intrinsic ubiquitin receptors, including proteasome regulatory particle base subunits 1, 10 and 13 (Rpn1, Rpn10, and Rpn13), determine the capability of the proteasome to recognize a ubiquitin chain, and thus provide selectivity for the 26S proteasome. However, the non-ubiquitin receptors, including proteasome activator 200 (PA200) and PA28γ, have received great attention due to their remarkable compensatory roles relative to canonical ubiquitin-mediated proteasomal degradation. Herein we review recent advances in understanding the contributions of these substrate receptors to proteasomal degradation, and introduce their substrates and interacting factors. We also provide insights into their biological functions related to spermatogenesis, immune responses, cellular homeostasis, and tumour development. Finally, we summarize advances in developing small-molecule inhibitors of these substrate receptors and discuss their potential as drug targets.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:93

Enthalten in:

Biological reviews of the Cambridge Philosophical Society - 93(2018), 4 vom: 16. Nov., Seite 1765-1777

Sprache:

Englisch

Beteiligte Personen:

Jiang, Tian-Xia [VerfasserIn]
Zhao, Mei [VerfasserIn]
Qiu, Xiao-Bo [VerfasserIn]

Links:

Volltext

Themen:

Drug targets
EC 3.4.25.1
Journal Article
PA200
PA28γ
Proteasomal degradation
Proteasome Endopeptidase Complex
Research Support, Non-U.S. Gov't
Review
Rpn1
Rpn10
Rpn13
Substrate receptor
Ubiquitinated Proteins
Ubiquitins

Anmerkungen:

Date Completed 25.03.2019

Date Revised 25.03.2019

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/brv.12419

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM283797339